Barely Significant
← all excerpts

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study.

Perspect Clin Res · 2015 · PMC4504059 · PMID 26229753

Europe PMCDOI
2
hedged sentences
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP < 0.0001actually significant
The reduction in PPG level was also highly significant in both groups ( P < 0.0001).

also in 132,142 other papers

did not reach statistical significanceno p-value reported
The combination of MF and VG showed little better adverse event profile than MF and GP though it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.